Tirzepatide
-
healthHealth Canada Approves Zepbound for Sleep Apnea in Obese Adults
The weight-loss drug becomes the first GLP-1 medication authorized in Canada to treat obstructive sleep apnea linked to obesity, offering a new option alongside CPAP therapy.
-
healthAI Analysis of Reddit Posts Reveals Potential Hidden Side Effects of Ozempic
Researchers used AI to analyze Reddit posts, uncovering unreported side effects of GLP-1 drugs like Ozempic and Wegovy.
-
healthIxekizumab and Tirzepatide Combo Boosts Psoriasis and Weight Outcomes
Phase 3b trial shows ixekizumab plus tirzepatide significantly improves skin clearance and weight loss in psoriasis patients with obesity.
-
healthOrforglipron Pill Sustains Weight Loss After Injection Discontinuation
New trial shows oral GLP-1 orforglipron helps maintain weight loss after stopping injectable therapies tirzepatide and semaglutide.
-
healthFDA Targets Copycat Weight-Loss Drugs, Limits Bulk Production
The FDA proposes removing Novo Nordisk and Eli Lilly's weight-loss drugs from a compounding list to curb unauthorized bulk production.
-
healthDoctor Flags 5 Common Pitfalls With Weight-Loss Drugs
A physician outlines critical mistakes patients make when using GLP-1 medications, emphasizing lifestyle changes, medical oversight, and proper nutrition for optimal results.
-
healthTirzepatide Linked to Greater Lean Mass Loss Than Semaglutide in New Analysis
Real-world study reveals tirzepatide patients may lose more lean body mass compared to semaglutide users, impacting metabolic health and aging.
-
healthDrug Combination Shows 35% Greater Weight Loss in Post-Menopausal Women
Mayo Clinic study reveals tirzepatide combined with hormone therapy delivers superior weight loss results for women over 50.